Page last updated: 2024-10-15

gamma-aminobutyric acid and Cachexia

gamma-aminobutyric acid has been researched along with Cachexia in 3 studies

gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.

Cachexia: General ill health, malnutrition, and weight loss, usually associated with chronic disease.

Research Excerpts

ExcerptRelevanceReference
"ECLIPSE (Evaluation of Chronic obstructive pulmonary disease to Longitudinally Identify Predictive Surrogate Endpoints) aims to identify biomarkers that correlate with clinically relevant COPD subtypes, and to assess how these may predict disease progression."2.77Targeted metabolomics identifies perturbations in amino acid metabolism that sub-classify patients with COPD. ( Cheng, KK; Connor, SC; Dong, J; Griffin, JL; Janowitz, T; Jodrell, D; Lomas, DA; MacNee, W; Riley, JH; Tal-Singer, R; Ubhi, BK, 2012)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ubhi, BK1
Cheng, KK1
Dong, J1
Janowitz, T1
Jodrell, D1
Tal-Singer, R1
MacNee, W1
Lomas, DA1
Riley, JH1
Griffin, JL1
Connor, SC1
Grewal, J1
Bril, V1
Lewis, GF1
Lewis, G1
Perkins, BA1
Derk, CT1
Cynwyd, B1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Multicentre 3 Year Longitudinal Prospective Study to Identify Novel Endpoints and Compare These With Forced Expiratory Volume in 1 Second (FEV1) for Their Ability to Measure and Predict COPD Severity and Its Progression Over Time[NCT00292552]2,747 participants (Actual)Observational2005-12-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for gamma-aminobutyric acid and Cachexia

ArticleYear
Targeted metabolomics identifies perturbations in amino acid metabolism that sub-classify patients with COPD.
    Molecular bioSystems, 2012, Oct-30, Volume: 8, Issue:12

    Topics: Aged; Amino Acids; Biomarkers; Body Mass Index; Cachexia; Disease Progression; Female; gamma-Aminobu

2012

Other Studies

2 other studies available for gamma-aminobutyric acid and Cachexia

ArticleYear
Objective evidence for the reversibility of nerve injury in diabetic neuropathic cachexia.
    Diabetes care, 2006, Volume: 29, Issue:2

    Topics: Adult; Amines; Amitriptyline; Analgesics; Antidepressive Agents, Tricyclic; Cachexia; Cyclohexanecar

2006
Malignant appearing cachexia in an older patient with Bruns-Garland syndrome.
    Journal of the American Geriatrics Society, 2000, Volume: 48, Issue:12

    Topics: Acetates; Aged; Amines; Analgesics; Cachexia; Cyclohexanecarboxylic Acids; Diabetes Mellitus, Type 2

2000